Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

Pablo Ochoa, Juan; Sabater‐Molina, María; Manuel García‐Pinilla, José; Mogensen, Jens; Alejandra Restrepo-Córdoba, María; Palomino-Doza, Julián; Villacorta, Eduardo; Martínez Moreno, Marina; Ramos‐Maqueda, Javier; Zorio, Esther; Luisa Peña‐Peña, María; Elpidio García-Granja, Pablo; F. Rodríguez‐Palomares, José; J. Cárdenas-Reyes, Ivonne; M. de la Torre‐Carpente, Maria; Bautista-Paves, A; Akhtar, Mohammed; Cicerchia, Marcos; Bilbao-Quesada, Raquel; Victoria Mogollón‐Jiménez, María; Salazar‐Mendiguchía, Joel; M. Mesa Latorre, José; Arnáez, Blanca; Olavarri-Miguel, Ivan; Eugenia Fuentes‐Cañamero, María; Lamounier, Arsonval; María Pérez Ruiz, José; Climent, Vicente; Pérez-Sánchez, Inmaculada; Pablo Trujillo‐Quintero, Juan; R. Lopes, Luís; Repáraz-Andrade, Alfredo; Marín-Iglesias, Rosario; Rodríguez-Vilela, Alejandro; Sandín‐Fuentes, María; Antonio Garrote, José; Cortel-Fuster, Alejandro; A. López-Garrido, Miguel; Fontalba-Romero, Ana; Ripoll‐Vera, Tomás; Llano‐Rivas, Isabel; Fernández, Xusto; Isidoro‐García, María; García-Giustiniani, Diego; Barriales‐Villa, Roberto; Ortiz-Genga, Martín; García‐Pavía, Pablo; Elliott, Perry; R. Gimeno, Juan; Monserrat, Lorenzo

doi:10.1016/j.jacc.2018.10.001

Public

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

Published in Journal of the American College of Cardiology • Nov 1, 2018

Authors:

Juan Pablo Ochoa

María Sabater‐Molina

José Manuel García‐Pinilla

Abstract

BACKGROUND: The genetic cause of hypertrophic cardiomyopathy remains unexplained in a substantial proportion of cases. Formin homology 2 domain containing 3 (FHOD3) may have a role in the pathogenesis of cardiac hypertrophy but has not been implicated in hypertrophic cardiomyopathy. OBJECTIVES: This...

Subject

Hypertrophic cardiomyopathy

Medicine

Odds ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!